Patents by Inventor G. Scott Herron

G. Scott Herron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8690863
    Abstract: Subjects treated with nonablative fractional photothermolysis (FP) have an intact stratum corneum, but can have microscopic lesions and vacuole formation within the epidermis. The vacuoles thus formed can trap dermal material and extrude it through the epidermis. Thus, FP can be used for the treatment of recalcitrant melasma, solar elastosis, and tattoos.
    Type: Grant
    Filed: October 10, 2006
    Date of Patent: April 8, 2014
    Assignee: Reliant Technologies, LLC
    Inventors: Kin F. Chan, Basil M. Hantash, G. Scott Herron, Vikramaditya P. Bedi
  • Patent number: 6906237
    Abstract: We report the use of telomerase-immortalized human microvascular endothelial cells in the formation of functional capillary blood vessels in vivo. Previously we showed the superior in vitro survival of human telomerase reverse transcriptase (hTERT)-transduced human endothelial cells. Here we show that retroviral-mediated transduction of hTERT in human dermal microvascular endothelial cells (HDMEC) results in cell lines that form microvascular structures when subcutaneously implanted in severe combined immunodeficiency (SCID) mice. The human origin of xenografted microvaculature was confirmed both by basement membrane immunoreactivity with anti-human type IV collagen staining and visualization of fluorescent vessels containing HDMEC that were co-transduced with hTERT and green fluorescent protein (eGFP). The lack of human vascular structures after implantation of HT1080 fibrosarcoma cells, 293 human embryonic kidney cells or human skin fibroblasts demonstrated the specificity of HDMEC at forming capillaries.
    Type: Grant
    Filed: February 27, 2001
    Date of Patent: June 14, 2005
    Inventor: G. Scott Herron
  • Publication number: 20030175961
    Abstract: The present invention relates to telomerase-immortalized microvascular endothelial cells that form microvascular structures in vitro and in vivo. The telomerized cells have normal karyotype and demonstrate resistance to apoptosis. Methods for producing the cells and specific applications of cell compositions are provided.
    Type: Application
    Filed: February 26, 2002
    Publication date: September 18, 2003
    Inventor: G. Scott Herron
  • Publication number: 20030170889
    Abstract: We report the use of telomerase-immortalized human microvascular endothelial cells in the formation of functional capillary blood vessels in vivo. Previously we showed the superior in vitro survival of human telomerase reverse transcriptase (hTERT)-transduced human endothelial cells. Here we show that retroviral-mediated transduction of hTERT in human dermal microvascular endothelial cells (HDMEC) results in cell lines that form microvascular structures when subcutaneously implanted in severe combined immunodeficiency (SCID) mice. The human origin of xenografted microvaculature was confirmed both by basement membrane immunoreactivity with anti-human type IV collagen staining and visualization of fluorescent vessels containing HDMEC that were co-transduced with hTERT and green fluorescent protein (eGFP). The lack of human vascular structures after implantation of HT1080 fibrosarcoma cells, 293 human embryonic kidney cells or human skin fibroblasts demonstrated the specificity of HDMEC at forming capillaries.
    Type: Application
    Filed: February 27, 2001
    Publication date: September 11, 2003
    Inventor: G. Scott Herron